Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07109427 · ClinicalTrials.gov registry record · NA

Impact of an Electronic Health Record Maintenance Alert on PSA Screening Rates in a 10-Hospital Integrated Health System

A NA study of Prostate Cancer and Cancer of the Prostate, sponsored by Washington University School of Medicine.

Recruiting
Registry status
NA
Development phase
40,000
Enrollment target
1
Study location

NCT07109427: Recruiting NA study of Prostate Cancer and Cancer of the Prostate, sponsored by Washington University School of Medicine.

NCT07109427 is a NA study of Prostate Cancer and Cancer of the Prostate that is actively recruiting participants, run by Washington University School of Medicine. The registered enrollment target is 40,000 participants, above the 554-participant average among 735 other Prostate Cancer trials with a reported enrollment target (7120% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07109427, a NA study of Prostate Cancer and Cancer of the Prostate, is actively recruiting participants, sponsored by Washington University School of Medicine.

RECRUITING
Registry status
NA
Development phase
40,000 participants
Enrollment target
1
Study location

Study Summary

\- The investigators propose a clinical trial to evaluate the impact of annual shared decision making for PSA screening, supported by system-level enhancements to promote evidence-based care: * Defined referral thresholds within the health maintenance reminder, aligned with clinical risk stratification per NCCN guidelines. * Enhanced clinical decision support (CDS) tools to reduce provider variation and ensure guideline-concordant screening and referral practices. * The goal is to reduce late-stage presentation without increasing overdiagnosis-ensuring that prostate cancer screening is both accessible and clinically effective.

Primary Outcome

The overall PSA screening rate will be calculated as the number of PSA screening tests that are ordered by PCPs who will receive the alert and completed by patients within a year of the ordering date, divided by the total number of eligible patients.

Interventions

  • OTHER Annual PSA Health Maintenance Reminder

Study Locations (1)

Missouri

  • Washington University School of Medicine - St Louis

Trial Details

FieldValue
Enrollment Target 40,000 participants
Start Date 2025-08-11
Est. Completion 2031-08-31
Phase NA

What NCT07109427 shows while recruiting

NCT07109427 is an interventional study that assigns participants to a tested intervention. Its 40,000 participants enrollment target places it among the larger protocols in the corpus, above the 554-participant average among 735 other Prostate Cancer trials with a reported enrollment target (7120% higher).

The record links to 2 conditions, with Prostate Cancer appearing as the primary indexed condition, and to 1 intervention - of which Annual PSA Health Maintenance Reminder is the first listed.

NCT07109427 reports a single indexed study location in Missouri.

Frequently Asked Questions

What is clinical trial NCT07109427 about?

NCT07109427 is a clinical study titled "Impact of an Electronic Health Record Maintenance Alert on PSA Screening Rates in a 10-Hospital Integrated Health System". \- The investigators propose a clinical trial to evaluate the impact of annual shared decision making for PSA screening, supported by system-level enhancements to promote evidence-based care: * Defined referral thresholds within the health maintenance reminder, aligned with clinical risk stratifica...

What is the current status of trial NCT07109427?

This trial is currently recruiting. It is a NA study. The enrollment target is 40,000 participants. The study started on 2025-08-11. Estimated completion is 2031-08-31.

What conditions does trial NCT07109427 study?

This clinical trial studies the following conditions: Prostate Cancer, Cancer of the Prostate.

What interventions are being tested in trial NCT07109427?

The interventions under investigation include: Annual PSA Health Maintenance Reminder (OTHER).

Who is sponsoring clinical trial NCT07109427?

This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07109427 being conducted?

This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Prostate Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT07109427's enrollment target sits among peer trials

40,000 2nd of 735 the highest of 735 other Prostate Cancer trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Prostate Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01255748 · 40,000 participants

    Registry Study for Radiation Therapy Outcomes

  • NCT04994756 · 40,000 participants

    Stroke Thrombectomy and Aneurysm Registry

  • NCT06768814 · 40,000 participants · NA

    Overdose Recovery and Care Access (ORCA) Qualitative Stakeholder Interviews and County-level Data

  • NCT05796505 · 37,122 participants · NA

    Addressing Vaccine Acceptance in Carceral Settings Through Community Engagement

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07109427, the US trial registry maintained by the National Library of Medicine. NCT07109427 (large enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.